Cancer Research UK logo.
SearchDonate
  • Search

A trial of a drug called tefinostat for liver cancer

Overview

Cancer types:

Liver cancer

Status:

Results

Phase:

Phase 1/2

Details

This trial looked at tefinostat for the most common type of liver cancer called hepatocellular carcinoma (HCC).

This trial was open for people to join between 2012 and 2017. The team reported the results in 2019.

Cancer Research UK supported this trial.

Recruitment start: 24 December 2012

Recruitment end: 11 May 2017

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr David Propper

Supported by

Cancer Research UK

Chroma Therapeutics

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Queen Mary University of London

Other information

This is Cancer Research UK trial number CRUKD/12/011.

Last reviewed: 28 September 2021

CRUK internal database number: 9047

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.